Kapanol 100 mg, Retardkapseln

( ARTG ) Management of Severe Pain: KAPANOL 10, 20, 50 and 100 mg capsules are indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term t​​​‍​​‍​​​​‍​​‍‍reatment. KAPANOL is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. KAPANOL is not indicated as an as-needed (PRN) analgesia.,Symptom Reduction of Chronic Breathlessness: KAPANOL 10 and 20 mg capsules are indicated for the symptomatic reduction of chronic breathlessness in the palliative care of patients with distressing breathlessness due to severe COPD, cardiac failure, malignancy or other cause. KAPANOL should only be used after treatments for the underlying cause(s) of the breathlessness have been optimised and nonpharmacological treatments are not effective. Treatment with KAPANOL in this setting should only be initiated by a specialist knowledgeable in its use.